SYNTAXIN
Syntaxin is a biopharmaceutical company that engineers and develops bacterial-based protein therapeutics for the treatment of neurological, inflammatory and endocrine diseases. The biopharmaceutical company's proprietary technology platform enables the engineering of bacterial proteins by domain substitution, to produce novel cell-specific biotherapeutics that inhibit cell secretion. These products can have therapeutic effects in a wide range of indications.
SYNTAXIN
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.syntaxin.com
Total Employee:
1001+
Status:
Active
Contact:
+33 1 58 33 50 00
Email Addresses:
[email protected]
Total Funding:
71.39 M USD
Technology used in webpage:
Apache Network Solutions DNS Citrix NetScaler Confluence Networks
Current Advisors List
Founder
Investors List
SR One
SR One investment in Series C - Syntaxin
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Syntaxin
Ipsen
Ipsen investment in Series C - Syntaxin
Seventure Partners
Seventure Partners investment in Series C - Syntaxin
Abingworth
Abingworth investment in Series C - Syntaxin
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Syntaxin
LSP BioVentures
LSP BioVentures investment in Series C - Syntaxin
SR One
SR One investment in Series B - Syntaxin
Quest for Growth
Quest for Growth investment in Series B - Syntaxin
Life Sciences Partners
Life Sciences Partners investment in Series B - Syntaxin
Official Site Inspections
http://www.syntaxin.com
- Host name: 64.190.63.222
- IP address: 64.190.63.222
- Location: Cleveland United States
- Latitude: 41.5043
- Longitude: -81.6786
- Metro Code: 510
- Timezone: America/New_York
- Postal: 44114
